27.11.2013 • News

Formosa Plastics Plans $2 Billion Ethane Cracker in Texas

One of Asia's largest chemicals and plastics producers, Taiwan-based Formosa Plastics, is seeking to cash in on the U.S. shale gas boom with its own $2 billion ethane cracker in Texas.

On a trip to Washington, D.C. as part of a Taiwanese business delegation, Formosa vice chairman Susan Wang said the company has already asked federal and state authorities for permission to expand its site at Port Comfort, Texas southwest of Houston and expects the green light within a year.

"Because of shale gas, the cost of making petrochemical- and plastic-related products is becoming very competitive here in the United States," Wang said in an interview with Bloomberg News, adding that "it's probably as cost effective as in the Middle East."

In 2012, Formosa announced that it would spend $1.7 billion on an integrated 800,000 t/y gas-fed cracker and a 300,000 t/y LDPE plant at Port Comfort, along with a 600,000 t/y dehydrogenation (PDH) plant to start up in 2016. Wang did not elaborate on what the additional $300,000 expenditure would cover.

The executive told Bloomberg that her company is "at a crossroads" in determining whether to build or invest in a naphtha cracker in the Chinese People's Republic after Taiwan last month lifted its ban on such investments.

Separately, press reports from Vietnam and Taiwan say that Formosa is planning to build a 200,000 t/y production facility for polystyrene in Vietnam's Nhon Trach industrial park, where it already produces manmade fibers, polyester and biaxially oriented polypropylene film (BOPP).

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.